These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29748147)

  • 1. 17-beta-hydroxysteroid dehydrogenase 13 inhibits the progression and recurrence of hepatocellular carcinoma.
    Chen J; Zhuo JY; Yang F; Liu ZK; Zhou L; Xie HY; Xu X; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):220-226. PubMed ID: 29748147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition.
    Lee N; Kwon JH; Kim YB; Kim SH; Park SJ; Xu W; Jung HY; Kim KT; Wang HJ; Choi KY
    Oncotarget; 2015 Oct; 6(30):30130-48. PubMed ID: 26375549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of sphingosine kinase 1 on the prognosis of hepatocellular carcinoma patients with portal vein tumor thrombus.
    Shi J; He YY; Sun JX; Guo WX; Li N; Xue J; Cheng SQ
    Ann Hepatol; 2015; 14(2):198-206. PubMed ID: 25671829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
    Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
    Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NEK2 Promotes Hepatoma Metastasis and Serves as Biomarker for High Recurrence Risk after Hepatic Resection.
    Chang YY; Yen CJ; Chan SH; Chou YW; Lee YP; Bao CY; Huang CJ; Huang W
    Ann Hepatol; 2018 Aug; 17(5):843-856. PubMed ID: 30145571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastastatic capacity of hepatocellular carcinoma.
    Liu Z; Ye Q; Wu L; Gao F; Xie H; Zhou L; Zheng S; Xu X
    Mol Carcinog; 2018 Nov; 57(11):1435-1444. PubMed ID: 29873415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.
    Ilboudo A; Nault JC; Dubois-Pot-Schneider H; Corlu A; Zucman-Rossi J; Samson M; Le Seyec J
    BMC Cancer; 2014 Jan; 14():7. PubMed ID: 24393405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy.
    Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M
    Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
    Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
    World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.
    Qiu X; Hu B; Huang Y; Deng Y; Wang X; Zheng F
    Dig Dis Sci; 2016 Jan; 61(1):149-57. PubMed ID: 26386860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.
    Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L
    Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDH1A1-overexpressing cells are differentiated cells but not cancer stem or progenitor cells in human hepatocellular carcinoma.
    Tanaka K; Tomita H; Hisamatsu K; Nakashima T; Hatano Y; Sasaki Y; Osada S; Tanaka T; Miyazaki T; Yoshida K; Hara A
    Oncotarget; 2015 Sep; 6(28):24722-32. PubMed ID: 26160842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decaprenyl diphosphate synthase subunit 2 as a prognosis factor in hepatocellular carcinoma.
    Huang W; Gao F; Li K; Wang W; Lai YR; Tang SH; Yang DH
    World J Gastroenterol; 2015 Mar; 21(10):3055-65. PubMed ID: 25780306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
    Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
    Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.